Tobramycin Inhalation Solution
Product Images NDC 66993-195

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Tobramycin Inhalation (NDC 66993-195). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prasco, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tobramycin Structural Formula (Tobramycin Inhalation Solution 1)

Chemical structure of tobramycin, the active ingredient in Tobramycin Inhalation 300 mg/4mL solution for respiratory inhalation by Prasco, LLC.*

FDA Label Image

Mouthpiece To Cup (Tobramycin Inhalation Solution 10)

An instructional diagram showing the insertion of a vial or capsule into a nebulizer chamber for inhalation treatment. The nebulizer includes a handle and circular top with a clamp mechanism, indicating assembly steps for Tobramycin Inhalation solution use by respiratory route.*

FDA Label Image

Inspiratory Valve (Tobramycin Inhalation Solution 11)

An instructional diagram showing the assembly or use of a respiratory inhalation device, including a mouthpiece and a container with a cap that is being placed on top. The illustration depicts components related to tobramycin inhalation solution use.*

FDA Label Image

Connect Tubing (Tobramycin Inhalation Solution 12)

An instructional illustration showing a hand inserting a plug or connector into the front panel of a Vios respiratory device. The device has a label area and a power switch visible.*

FDA Label Image

Plug In Compressor (Tobramycin Inhalation Solution 13)

An illustration showing a hand plugging a two-prong electrical plug into a wall outlet, demonstrating proper connection to a power source.*

FDA Label Image

Tubing Into Air Intake (Tobramycin Inhalation Solution 14)

An instructional diagram showing a nebulizer device used for respiratory inhalation. The image depicts the mouthpiece at the top left, a cylindrical medication chamber, and an airflow pathway below indicating the direction of aerosolized medication output.*

FDA Label Image

Turn On Compressor (Tobramycin Inhalation Solution 15)

An instructional illustration showing a hand pressing a button on a Vios device, which is used for the inhalation of Tobramycin solution. The device features a power switch and a port for attaching the inhalation tubing or mouthpiece.*

FDA Label Image

Mist Check (Tobramycin Inhalation Solution 16)

Illustration showing a hand operating a nebulizer device designed for delivering Tobramycin Inhalation solution via respiratory inhalation. The image depicts the nebulizer cup and mouthpiece with medication mist, demonstrating the inhalation process for the 300 mg/4 mL dosage form by Prasco, LLC.*

FDA Label Image

Mouthpiece Into Mouth (Tobramycin Inhalation Solution 17)

An instructional line drawing illustrating a person using a nebulizer device for inhalation therapy. The device is shown delivering a mist-like aerosol into the person's mouth, demonstrating the respiratory administration of an inhalation solution.*

FDA Label Image

Tobramycin Inhalation Solution Carton (Tobramycin Inhalation Solution 18)

Box label for Tobramycin Inhalation Solution 300 mg/4 mL by Prasco, LLC. The label indicates the solution is for oral inhalation only by nebulizer, single-use ampules with disposal instructions, storage requirements in a refrigerator, and contains 56 single-use ampules (28-day supply). The label also includes the NDC 66993-195-94 and distributor information.*

FDA Label Image

Tobramycin Inhalation Solution Foil Pouch (Tobramycin Inhalation Solution 19)

The packaging label for Tobramycin Inhalation Solution 300 mg/4 mL by Prasco Laboratories. It is indicated for oral inhalation by nebulizer, provided as single-use ampules in foil pouches containing 4 ampules. The label includes storage instructions to refrigerate at 2°C to 8°C and protect from intense light, with a caution that unopened ampules should be returned to the foil pouch. It also notes the solution contains 300 mg Tobramycin and 18 mg sodium chloride per 4 mL, with no preservatives.*

FDA Label Image

Fev1 (Tobramycin Inhalation Solution 2)

A line graph showing the percentage change from baseline in FEV1 predicted over 24 weeks in two studies involving Tobramycin Inhalation Solution and placebo groups. The x-axis represents weeks, with periods labeled "on drug," and the y-axis shows FEV1% predicted change. Data lines differentiate Tobramycin (Studies 1 and 2) and placebo groups, indicating different patient numbers (N=29, 161, and 84 respectively).*

FDA Label Image

Tobramycin Inhalation Solution Ampule (Tobramycin Inhalation Solution 20)

Text panel showing the product name Tobramycin Inhalation Solution with a strength of 300 mg per 4 mL. The text is displayed in blue font on a white background.*

FDA Label Image

Figure A (Tobramycin Inhalation Solution 3)

An instructional diagram showing components of the Tobramycin Inhalation solution administration set. It includes a PARI LC PLUS reusable nebulizer with labeled parts, a mouthpiece, a PARI Vios compressor, tubing, a nose clip, a clean paper towel, and a single ampule of Tobramycin Inhalation Solution. The diagram highlights assembly and parts used for respiratory inhalation therapy.*

FDA Label Image

Figure B (Tobramycin Inhalation Solution 4)

Tobramycin Inhalation Solution 300 mg/4 mL ampule package showing a foil pouch containing four single-use ampules. The label instructs storage at 2°C to 8°C (36°F to 46°F) and single use by nebulizer only. The front and inside of the foil pouch are visible, displaying individual ampules labeled with the strength and proprietary name.*

FDA Label Image

Figure C (Tobramycin Inhalation Solution 5)

An instructional illustration showing two hands holding multiple ampules, each labeled '300 mg/4 mL Tobramycin Inhalation, solution'. The image demonstrates handling of Tobramycin Inhalation solution ampules for respiratory use.*

FDA Label Image

Open Ampule (Tobramycin Inhalation Solution 6)

An instructional line drawing showing two hands opening a small single-dose vial, likely a unit dose of Tobramycin Inhalation solution, by twisting or breaking the tip to access the medication for respiratory inhalation.*

FDA Label Image

Open Nebulizer Cap (Tobramycin Inhalation Solution 7)

An instructional line drawing showing two hands assembling or adjusting a nebulizer device. The diagram labels the nebulizer cup top and nebulizer cup outlet, with an arrow indicating the direction upwards from the cup top. The illustration appears to demonstrate how to open or fill the nebulizer cup for inhalation use.*

FDA Label Image

Transfer Medicine To Nebulizer Cup (Tobramycin Inhalation Solution 8)

An instructional line drawing showing two hands assembling or preparing a respiratory inhalation device. One hand holds a vial or ampule and inserts it into the top of the inhaler while the other hand stabilizes the inhaler body, demonstrating how to load the medication for inhalation.*

FDA Label Image

Close Nebulizer Cup (Tobramycin Inhalation Solution 9)

An instructional black-and-white line drawing depicting hands assembling a nebulizer. It shows lifting the nebulizer cup top from the nebulizer cup outlet with arrows indicating the assembly direction. The parts are labeled accordingly.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.